ForCast Orthopedics Receives Orphan Drug Designation From FDA for the Treatment of Periprosthetic Joint Infection (PJI)
Health - Purple Foxy Ladies originally published at Health - Purple Foxy Ladies
DENVER, June 27, 2023 (Newswire.com) - ForCast Orthopedics today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for ForCast's lead program, FC001, for the treatment of periprosthetic joint infection (PJI).
PJI is a rare but serious complication of joint replacement procedures that can threaten the function of the joint, the preservation of the limb and even the life of the patient. PJI is challenging to treat because the infecting bacteria adhere to the prothesis and form a protective biofilm that can be resistant to standard systemic antibiotics.
FC001 is being developed to address these challenges by delivering a targeted antibiotic therapy directly into the infected joint using ForCast's proprietary technology.
The FDA's Office of Orphan Drug Products grants orphan status to support the development of medicines for rare disorders that affect fewer than 200,000 people in the United States. Orphan drug designation provides certain benefits, including market exclusivity upon regulatory approval, assistance during the development process, exemption from certain FDA fees, and tax credits for qualified clinical trials.
"We are extremely pleased to receive Orphan Drug designation from the FDA," said Peter Noymer, PhD, Executive Chairman and CEO of ForCast Orthopedics. "Along with the recent designation of FC001 as a Qualified Infectious Disease Product (QIDP) by the FDA, this helps to further validate the potential superiority of our approach to treating PJI relative to the current standard of care."
"This is a great achievement for ForCast and an even greater signal to PJI patients about our commitment to improving the treatment options available to them," added Jared Foran, MD, Chief Scientific Officer and co-founder of ForCast Orthopedics.
About ForCast Orthopedics
ForCast is a development-stage company with a focus on pioneering the treatment of periprosthetic joint infection (PJI) with targeted antibiotic therapy. Our mission is to modernize the standard of care for PJI and improve the quality of life for the growing population of joint replacement patients.
Contact:
Peter Noymer, PhD
Executive Chairman and CEO
pnoymer@forcastortho.com
Contact Information:Peter Noymer
Executive Chairman and CEO
pnoymer@forcastortho.com
Original Source: ForCast Orthopedics Receives Orphan Drug Designation From FDA for the Treatment of Periprosthetic Joint Infection (PJI)
Health - Purple Foxy Ladies originally published at Health - Purple Foxy Ladies
More Stories
North Shore Pediatric Therapy Expands Locations & Offers Rapid Early Autism Testing Amidst National Waitlists
Autism testing for kids 4 and under in Arlington Heights, Deerfield, and Naperville fills a much-needed gap for local families.
North Shore Pediatr…
DocVA Launches Cutting-Edge Virtual Medical Assistant Services, Revolutionizing Healthcare Operations
Boost Efficiency and Elevate Patient Care With DocVA’s New Virtual Assistant Services
FORT LAUDERDALE, Fla., July 18, 2024 (Newswire.com)
–
DocVA, a leader in the virtual medical assistant staffing industry with years of experience, announces the launch of its comprehensive suite of remote healthcare support services. This innovative offering aims to transform medical practices by providing highly skilled virtual assistants capable of handling various administrative and clinical support tasks.
Virtual Medical Assistant Provider Offers Tailored Solutions to Enhance Patient Care and Streamline Practice Operations
“The world of healthcare is constantly changing, and at DocVA, we’re committed to staying ahead of the curve,” said Nathaniel Barz, CEO of DocVA, who has a decade of experience delivering excellent customer service in the staffing industry. “Our mission is to help as many healthcare practices as possible in the U.S., Canada, and eventually the world by addressing the critical issues that arose post-COVID, such as staff burnout and shortages.”
Comprehensive Virtual Medical Assistant Services
DocVA’s range of services includes:
- Virtual Medical Receptionist: Handling phone calls, scheduling appointments, managing prescription refill requests, and verifying insurance eligibility
- Virtual Medical Billing and Insurance Assistant: Managing payments, insurance verification, claims submissions, and pre-authorizations
- Virtual Medical Assistant: Updating medical records, coordinating with other providers, and fielding patient questions
- Virtual Medical Scribe: Providing real-time documentation during patient exams, ensuring EMRs stay current
Benefits for All Stakeholders
By partnering with DocVA, healthcare providers can expect:
- Improved office efficiency and smoother daily operations
- Enhanced patient satisfaction through elite-level customer service
- Significant cost savings compared to hiring in-house staff
- HIPAA-compliant services that ensure patient privacy and data security
- Flexibility to scale support based on practice needs
- Reduced staff burnout and improved work-life balance
- Increased profitability for practices
“Our virtual assistants create a win-win-win situation,” Nathan added. “Staff love it, doctors love it, and patients love it. We’re not just improving healthcare operations but also providing opportunities for people in developing countries to achieve an upper-middle-class lifestyle.”
About DocVA
DocVA is a seasoned virtual medical assistant staffing leader, with two years of specialized experience in the healthcare industry. Our team has placed thousands of virtual medical assistants in different practices across the U.S. Building on lessons learned from previous ventures, DocVA is dedicated to constant improvement and innovation. By leveraging cutting-edge AI technology and a team of highly skilled professionals, DocVA enables medical practices to streamline operations, improve patient care, and reduce operational costs.
Discover more about how DocVA is revolutionizing healthcare support at https://docva.com or contact:
Contact Information:
Nathaniel Barz
Founder & CEO
DocVA
clientmanager@docva.com
+1 (954) 304-9702
110 E. Broward Blvd., Suite 1700, Fort Lauderdale, Florida 33312, United States
Contact Information:
Nathaniel Barz
CEO
+1 (954) 304-9702
Original Source:
DocVA Launches Cutting-Edge Virtual Medical Assistant Services, Revolutionizing Healthcare Operations
Protenus Granted Seventh Patent for Drug Diversion Surveillance Technology
New patent granted assists hospitals with greater coverage to support drug waste events
Protenus Protenus logo
BA…
HydroCorp Redefines Piping Schematics at Leading Clinic Hospital Network
Enhancing water and medical gas system management and emergency preparedness through comprehensive visual surveying documentation
Piping hazard ide…
PRISM Vision Group at ASRS Annual Meeting — Stockholm, Sweden
PRISM Vision Group-affiliated physicians are well represented at the ASRS Annual Meeting.
NEW PROVIDENCE, N.J., July 17, …
LEARNROLL LLC Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
American Heart Association consortium advances development of evidence-based health tech solutions
Learnroll Logo
…